Johnson & Johnson Property, Plant, and Equipment 2010-2024 | JNJ
Johnson & Johnson property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- Johnson & Johnson property, plant, and equipment for the quarter ending September 30, 2024 was $20.479B, a 8.81% increase year-over-year.
- Johnson & Johnson property, plant, and equipment for 2023 was $19.898B, a 10.66% increase from 2022.
- Johnson & Johnson property, plant, and equipment for 2022 was $17.982B, a 5.17% decline from 2021.
- Johnson & Johnson property, plant, and equipment for 2021 was $18.962B, a 1.04% increase from 2020.
Johnson & Johnson Annual Property, Plant, and Equipment
(Millions of US $) |
| 2023 |
$19,898 |
| 2022 |
$17,982 |
| 2021 |
$18,962 |
| 2020 |
$18,766 |
| 2019 |
$17,658 |
| 2018 |
$17,035 |
| 2017 |
$17,005 |
| 2016 |
$15,912 |
| 2015 |
$15,905 |
| 2014 |
$16,126 |
| 2013 |
$16,710 |
| 2012 |
$16,097 |
| 2011 |
$14,739 |
| 2010 |
$14,553 |
| 2009 |
$14,759 |
Johnson & Johnson Quarterly Property, Plant, and Equipment
(Millions of US $) |
| 2024-09-30 |
$20,479 |
| 2024-06-30 |
$19,748 |
| 2024-03-31 |
$19,632 |
| 2023-12-31 |
$19,898 |
| 2023-09-30 |
$18,821 |
| 2023-06-30 |
$20,576 |
| 2023-03-31 |
$20,174 |
| 2022-12-31 |
$17,982 |
| 2022-09-30 |
$18,152 |
| 2022-06-30 |
$18,354 |
| 2022-03-31 |
$18,701 |
| 2021-12-31 |
$18,962 |
| 2021-09-30 |
$18,478 |
| 2021-06-30 |
$18,632 |
| 2021-03-31 |
$18,367 |
| 2020-12-31 |
$18,766 |
| 2020-09-30 |
$17,855 |
| 2020-06-30 |
$17,598 |
| 2020-03-31 |
$17,401 |
| 2019-12-31 |
$17,658 |
| 2019-09-30 |
$17,048 |
| 2019-06-30 |
$17,248 |
| 2019-03-31 |
$17,000 |
| 2018-12-31 |
$17,035 |
| 2018-09-30 |
$16,629 |
| 2018-06-30 |
$16,632 |
| 2018-03-31 |
$17,040 |
| 2017-12-31 |
$17,005 |
| 2017-09-30 |
$16,628 |
| 2017-06-30 |
$16,458 |
| 2017-03-31 |
$16,191 |
| 2016-12-31 |
$15,912 |
| 2016-09-30 |
$16,095 |
| 2016-06-30 |
$15,972 |
| 2016-03-31 |
$15,964 |
| 2015-12-31 |
$15,905 |
| 2015-09-30 |
$15,551 |
| 2015-06-30 |
$15,583 |
| 2015-03-31 |
$15,364 |
| 2014-12-31 |
$16,126 |
| 2014-09-30 |
$15,804 |
| 2014-06-30 |
$16,155 |
| 2014-03-31 |
$15,996 |
| 2013-12-31 |
$16,710 |
| 2013-09-30 |
$16,127 |
| 2013-06-30 |
$15,794 |
| 2013-03-31 |
$15,721 |
| 2012-12-31 |
$16,097 |
| 2012-09-30 |
$15,845 |
| 2012-06-30 |
$15,622 |
| 2012-03-31 |
$14,824 |
| 2011-12-31 |
$14,739 |
| 2011-09-30 |
$14,635 |
| 2011-06-30 |
$14,974 |
| 2011-03-31 |
$15,084 |
| 2010-12-31 |
$14,553 |
| 2010-09-30 |
$14,360 |
| 2010-06-30 |
$13,881 |
| 2010-03-31 |
$14,277 |
| 2009-12-31 |
$14,759 |
| 2009-09-30 |
$14,815 |
| 2009-06-30 |
$14,502 |
| 2009-03-31 |
$14,253 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$368.366B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
